Twilight Litaka key developments

Twilight Litaka Pharma Ltd has informed about the key developments which took place up to November 15, 2007.

- Company's "Nutra" Division has taken off and has started marketing in South, East, and West of the Country, eight prod namely CoQ Care, Arthicare SR, Antox Care, Bio Iron, Ocu Care, Uneed, Movital and Calm Cream were introduced. These products are well received in the market and initial response from the Doctors as well as customers has been very encouraging.

- Company has also launched five additional antibiotics namely, Zoxin, Lariclav, Amfect, Tufpime and Litazith. These brands include a range of injectibles which are showing a promising growth.

- Company has added 400 more representatives, making the total strength to around 1000 personnel. The added strength in the marketing division will enable the Company to reach its targets within the stipulated time.

- During the last six months Company's Domestic Sales has grown by 50%.